Development and validation of a machine learning model for real-time prediction of invasive mechanical ventilation weaning readiness
- PMID: 40435812
- DOI: 10.1016/j.jcrc.2025.155105
Development and validation of a machine learning model for real-time prediction of invasive mechanical ventilation weaning readiness
Abstract
Purpose: To develop and validate a bedside machine learning (ML) decision support tool for prediction of invasive mechanical ventilation (IMV) weaning readiness.
Methods: Adults admitted after 2010 who underwent IMV (>24 h) were included from MIMIC-IV (development and internal validation) and AmsterdamUMCdb (external validation) databases. XGBoost boosted trees approach was used to develop three models predicting IMV weaning readiness within 24, 48, and 72 h by integrating electronic health record data. The areas under Receiver Operating Characteristic (auROC), the Precision-Recall curve (auPR) curves, and performance metrics were assessed. Sensitivity analyses evaluated the impact of gender, ethnicity, age and admission reason on model performance.
Results: 8565 patients from MIMIC-IV and 2626 from AmsterdamUMCdb were included. In the external validation cohort, the 24-, 48-, and 72-h models had auROCs of 0.847, 0.795 and 0.789, and auPR of 54.17, 54.56 and 59.4, respectively. Sensitivity was >0.75 for all models, but specificity decreased from 0.79 to 0.63 between the 24-h and 72-h models. Lower performances were observed for older (> 60 years) and neurosurgical patients.
Conclusions: This study presents three ML models for real-time prediction of IMV weaning readiness, offering a promising approach to enhance clinical decision-making and optimize patient care.
Keywords: Invasive mechanical ventilation; Machine-learning; Respiratory failure; Weaning.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest VS and GG have no competing interest regarding the submitted paper. LR has received consulting fees from U-Care Medical for this research work. AA is CEO of U-Care Medical. FA and AA are shareholder of U-Care Medical. FA and SZ are employees of U-Care Medical. AA, FA and SZ filed for the European Patent Application No. 24202572.4 “System and method for management and prediction of invasive mechanical ventilation necessity”.
